| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | COL2A1 COL4A3 COL4A4 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL28A1 COL27A1 COL5A3 COL6A5 COL22A1 COL1A1 | 4.50e-29 | 46 | 50 | 15 | GO:0030020 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL2A1 COL4A3 COL4A4 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL28A1 COL27A1 COL5A3 COL6A5 COL22A1 COL1A1 | 3.88e-19 | 188 | 50 | 15 | GO:0005201 |
| GeneOntologyMolecularFunction | structural molecule activity | COL2A1 COL4A3 COL4A4 COL4A6 COL6A3 H1-8 COL9A1 COL9A3 COL16A1 COL21A1 COL28A1 COL27A1 NUP98 COL5A3 COL6A5 COL22A1 COL1A1 | 2.33e-11 | 891 | 50 | 17 | GO:0005198 |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 3.99e-04 | 12 | 50 | 2 | GO:0048407 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 1.06e-03 | 180 | 50 | 4 | GO:0004866 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 1.23e-03 | 187 | 50 | 4 | GO:0030414 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 1.60e-03 | 201 | 50 | 4 | GO:0061135 | |
| GeneOntologyMolecularFunction | cargo adaptor activity | 1.78e-03 | 25 | 50 | 2 | GO:0140312 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL2A1 COL4A3 COL4A4 COL4A6 COL9A1 COL9A3 COL16A1 COL28A1 COL27A1 COL5A3 COL22A1 COL1A1 | 4.50e-11 | 377 | 48 | 12 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL2A1 COL4A3 COL4A4 COL4A6 COL9A1 COL9A3 COL16A1 COL28A1 COL27A1 COL5A3 COL22A1 COL1A1 | 4.64e-11 | 378 | 48 | 12 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL2A1 COL4A3 COL4A4 COL4A6 COL9A1 COL9A3 COL16A1 COL28A1 COL27A1 COL5A3 COL22A1 COL1A1 | 4.79e-11 | 379 | 48 | 12 | GO:0045229 |
| GeneOntologyBiologicalProcess | collagen fibril organization | 8.99e-07 | 76 | 48 | 5 | GO:0030199 | |
| GeneOntologyBiologicalProcess | collagen-activated tyrosine kinase receptor signaling pathway | 2.56e-06 | 12 | 48 | 3 | GO:0038063 | |
| GeneOntologyBiologicalProcess | cartilage development involved in endochondral bone morphogenesis | 4.28e-06 | 47 | 48 | 4 | GO:0060351 | |
| GeneOntologyBiologicalProcess | collagen-activated signaling pathway | 9.42e-06 | 18 | 48 | 3 | GO:0038065 | |
| GeneOntologyBiologicalProcess | endochondral bone morphogenesis | 3.41e-05 | 79 | 48 | 4 | GO:0060350 | |
| GeneOntologyBiologicalProcess | bone morphogenesis | 1.97e-04 | 124 | 48 | 4 | GO:0060349 | |
| GeneOntologyBiologicalProcess | glomerular basement membrane development | 2.36e-04 | 10 | 48 | 2 | GO:0032836 | |
| GeneOntologyCellularComponent | collagen trimer | COL2A1 COL4A3 COL4A4 COL4A6 COL6A3 COL9A1 COL9A3 GLDN COL16A1 COL21A1 COL28A1 COL27A1 COL5A3 COL6A5 COL22A1 MARCO COL1A1 | 4.63e-29 | 88 | 49 | 17 | GO:0005581 |
| GeneOntologyCellularComponent | complex of collagen trimers | 9.93e-17 | 21 | 49 | 8 | GO:0098644 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | COL2A1 COL4A3 COL4A4 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL28A1 COL27A1 COL5A3 COL22A1 COL1A1 | 2.02e-14 | 332 | 49 | 14 | GO:0005788 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL2A1 COL4A3 COL4A4 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL28A1 COL27A1 COL5A3 COL6A5 COL22A1 MARCO COL1A1 | 3.61e-14 | 530 | 49 | 16 | GO:0062023 |
| GeneOntologyCellularComponent | extracellular matrix | COL2A1 COL4A3 COL4A4 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL28A1 COL27A1 COL5A3 COL6A5 COL22A1 MARCO COL1A1 | 9.44e-13 | 656 | 49 | 16 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL2A1 COL4A3 COL4A4 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL28A1 COL27A1 COL5A3 COL6A5 COL22A1 MARCO COL1A1 | 9.89e-13 | 658 | 49 | 16 | GO:0030312 |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 4.49e-11 | 12 | 49 | 5 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 4.49e-11 | 12 | 49 | 5 | GO:0098643 | |
| GeneOntologyCellularComponent | collagen type IX trimer | 4.83e-08 | 4 | 49 | 3 | GO:0005594 | |
| GeneOntologyCellularComponent | FACIT collagen trimer | 2.41e-07 | 6 | 49 | 3 | GO:0005593 | |
| GeneOntologyCellularComponent | collagen type IV trimer | 2.41e-07 | 6 | 49 | 3 | GO:0005587 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 6.72e-07 | 8 | 49 | 3 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 6.72e-07 | 8 | 49 | 3 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 6.72e-07 | 8 | 49 | 3 | GO:0098645 | |
| GeneOntologyCellularComponent | basement membrane | 9.68e-06 | 122 | 49 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | collagen type V trimer | 3.22e-05 | 4 | 49 | 2 | GO:0005588 | |
| GeneOntologyCellularComponent | supramolecular polymer | COL2A1 COL4A3 COL4A4 COL4A6 COL6A3 COL28A1 COL27A1 COL5A3 COL1A1 | 1.56e-03 | 1187 | 49 | 9 | GO:0099081 |
| HumanPheno | Abnormality of the elbow | 2.15e-06 | 282 | 18 | 8 | HP:0009811 | |
| HumanPheno | Coxa vara | 2.74e-06 | 68 | 18 | 5 | HP:0002812 | |
| HumanPheno | Arthralgia of the hip | 3.07e-06 | 9 | 18 | 3 | HP:0003365 | |
| HumanPheno | Waddling gait | 3.55e-06 | 130 | 18 | 6 | HP:0002515 | |
| HumanPheno | Lenticonus | 4.38e-06 | 10 | 18 | 3 | HP:0001142 | |
| HumanPheno | Schmorl's node | 1.18e-05 | 2 | 18 | 2 | HP:0030041 | |
| HumanPheno | Internal tibial torsion | 1.18e-05 | 2 | 18 | 2 | HP:0034372 | |
| HumanPheno | Abnormal femoral neck morphology | 1.19e-05 | 160 | 18 | 6 | HP:0003367 | |
| HumanPheno | Coxa valga | 1.23e-05 | 92 | 18 | 5 | HP:0002673 | |
| HumanPheno | Knee pain | 2.44e-05 | 17 | 18 | 3 | HP:0030839 | |
| HumanPheno | Abnormality of lens shape | 2.93e-05 | 18 | 18 | 3 | HP:0011526 | |
| HumanPheno | Joint laxity | 3.33e-05 | 55 | 18 | 4 | HP:0001388 | |
| HumanPheno | Glomerular basement membrane lamellation | 3.53e-05 | 3 | 18 | 2 | HP:0030034 | |
| HumanPheno | Epiphyseal deformities of tubular bones | 3.53e-05 | 3 | 18 | 2 | HP:0003053 | |
| HumanPheno | Fragmentation of the metacarpal epiphyses | 3.53e-05 | 3 | 18 | 2 | HP:0009189 | |
| HumanPheno | Fragmented epiphyses of the upper limbs | 3.53e-05 | 3 | 18 | 2 | HP:0003841 | |
| HumanPheno | Radially deviated wrists | 3.53e-05 | 3 | 18 | 2 | HP:0006190 | |
| HumanPheno | Anterior lenticonus | 3.53e-05 | 3 | 18 | 2 | HP:0011501 | |
| HumanPheno | Abnormality of the epiphyses of the elbow | 3.53e-05 | 3 | 18 | 2 | HP:0003946 | |
| HumanPheno | Thin glomerular basement membrane | 3.53e-05 | 3 | 18 | 2 | HP:0012577 | |
| HumanPheno | Limb pain | 3.84e-05 | 57 | 18 | 4 | HP:0009763 | |
| HumanPheno | Joint hypermobility | COL2A1 AP4E1 COL6A3 COL9A1 COL9A3 GALNS CAMTA1 ARID1A COL1A1 | 4.11e-05 | 557 | 18 | 9 | HP:0001382 |
| HumanPheno | Abnormal femoral neck/head morphology | 4.37e-05 | 201 | 18 | 6 | HP:0003366 | |
| HumanPheno | Platyspondyly | 5.24e-05 | 124 | 18 | 5 | HP:0000926 | |
| HumanPheno | Vitreoretinopathy | 5.47e-05 | 22 | 18 | 3 | HP:0007773 | |
| HumanPheno | Osteoarthritis | 6.46e-05 | 65 | 18 | 4 | HP:0002758 | |
| HumanPheno | Myopia | 6.56e-05 | 447 | 18 | 8 | HP:0000545 | |
| HumanPheno | Ulnar deviated club hands | 7.05e-05 | 4 | 18 | 2 | HP:0006055 | |
| HumanPheno | Abnormality of the distal femoral epiphysis | 7.05e-05 | 4 | 18 | 2 | HP:0010590 | |
| HumanPheno | Reduced arm span | 7.05e-05 | 4 | 18 | 2 | HP:0012770 | |
| HumanPheno | Small epiphyses | 7.16e-05 | 24 | 18 | 3 | HP:0010585 | |
| HumanPheno | Irregular epiphyses | 8.12e-05 | 25 | 18 | 3 | HP:0010582 | |
| HumanPheno | Fragmented epiphyses | 1.17e-04 | 5 | 18 | 2 | HP:0100168 | |
| HumanPheno | Keratan sulfate excretion in urine | 1.17e-04 | 5 | 18 | 2 | HP:0012069 | |
| HumanPheno | Degenerative vitreoretinopathy | 1.17e-04 | 5 | 18 | 2 | HP:0007964 | |
| HumanPheno | Epiphyseal dysplasia | 1.28e-04 | 29 | 18 | 3 | HP:0002656 | |
| HumanPheno | Irregular vertebral endplates | 1.42e-04 | 30 | 18 | 3 | HP:0003301 | |
| HumanPheno | Joint subluxation | 1.57e-04 | 31 | 18 | 3 | HP:0032153 | |
| HumanPheno | Abnormality of radial epiphyses | 1.75e-04 | 6 | 18 | 2 | HP:0003999 | |
| HumanPheno | Abnormal knee physiology | 2.02e-04 | 87 | 18 | 4 | HP:0034670 | |
| HumanPheno | Limited elbow movement | 2.22e-04 | 168 | 18 | 5 | HP:0002996 | |
| HumanPheno | Abnormality of the epiphyses of the feet | 2.45e-04 | 7 | 18 | 2 | HP:0010631 | |
| HumanPheno | Abnormal lower limb epiphysis morphology | 2.73e-04 | 94 | 18 | 4 | HP:0006500 | |
| HumanPheno | Abnormality of the vertebral endplates | 2.89e-04 | 38 | 18 | 3 | HP:0005106 | |
| HumanPheno | Cervical myelopathy | 3.26e-04 | 8 | 18 | 2 | HP:0002318 | |
| HumanPheno | Lower limb pain | 3.63e-04 | 41 | 18 | 3 | HP:0012514 | |
| HumanPheno | Lumbar kyphosis | 4.18e-04 | 9 | 18 | 2 | HP:0008454 | |
| HumanPheno | Abnormal femur morphology | 4.33e-04 | 304 | 18 | 6 | HP:0002823 | |
| HumanPheno | Abnormal patella morphology | 4.82e-04 | 109 | 18 | 4 | HP:0003045 | |
| HumanPheno | Intervertebral space narrowing | 5.22e-04 | 10 | 18 | 2 | HP:0002945 | |
| HumanPheno | Cigarette-paper scars | 5.22e-04 | 10 | 18 | 2 | HP:0001073 | |
| HumanPheno | Irregular femoral epiphysis | 5.22e-04 | 10 | 18 | 2 | HP:0006361 | |
| HumanPheno | Bowing of the long bones | 5.33e-04 | 316 | 18 | 6 | HP:0006487 | |
| HumanPheno | Generalized joint hypermobility | 5.80e-04 | 48 | 18 | 3 | HP:0002761 | |
| HumanPheno | Anomaly of the limb diaphyses | 5.90e-04 | 322 | 18 | 6 | HP:0006504 | |
| HumanPheno | Abnormality of the thigh | 5.90e-04 | 322 | 18 | 6 | HP:0001439 | |
| HumanPheno | Abnormal vitreous humor morphology | 6.17e-04 | 49 | 18 | 3 | HP:0004327 | |
| HumanPheno | Cervical subluxation | 6.37e-04 | 11 | 18 | 2 | HP:0003308 | |
| HumanPheno | Abnormal arm span | 6.37e-04 | 11 | 18 | 2 | HP:0012769 | |
| HumanPheno | Abnormal morphology of the radius | 7.28e-04 | 217 | 18 | 5 | HP:0002818 | |
| HumanPheno | Rhegmatogenous retinal detachment | 7.62e-04 | 12 | 18 | 2 | HP:0012230 | |
| HumanPheno | Radial deviation of the hand | 7.62e-04 | 12 | 18 | 2 | HP:0009486 | |
| HumanPheno | Thickened glomerular basement membrane | 7.62e-04 | 12 | 18 | 2 | HP:0004722 | |
| HumanPheno | Abnormal diaphysis morphology | 8.27e-04 | 343 | 18 | 6 | HP:0000940 | |
| HumanPheno | Flat capital femoral epiphysis | 8.99e-04 | 13 | 18 | 2 | HP:0003370 | |
| HumanPheno | Abnormal glomerular basement membrane morphology | 8.99e-04 | 13 | 18 | 2 | HP:0033282 | |
| HumanPheno | Bilateral coxa valga | 8.99e-04 | 13 | 18 | 2 | HP:0010665 | |
| HumanPheno | Abnormality of the knee | 9.16e-04 | 491 | 18 | 7 | HP:0002815 | |
| HumanPheno | Abnormal hip bone morphology | 9.37e-04 | 653 | 18 | 8 | HP:0003272 | |
| HumanPheno | Glomerular subepithelial deposits | 1.05e-03 | 14 | 18 | 2 | HP:0033603 | |
| HumanPheno | Postexertional symptom exacerbation | 1.05e-03 | 14 | 18 | 2 | HP:0030973 | |
| HumanPheno | Flattened femoral epiphysis | 1.05e-03 | 14 | 18 | 2 | HP:0030289 | |
| HumanPheno | Neonatal short-limb short stature | 1.05e-03 | 14 | 18 | 2 | HP:0008921 | |
| HumanPheno | Abnormal hand epiphysis morphology | 1.06e-03 | 59 | 18 | 3 | HP:0005924 | |
| HumanPheno | Abnormal forearm bone morphology | 1.07e-03 | 236 | 18 | 5 | HP:0040072 | |
| HumanPheno | Limited elbow extension | 1.12e-03 | 60 | 18 | 3 | HP:0001377 | |
| HumanPheno | Abnormal forearm morphology | 1.13e-03 | 239 | 18 | 5 | HP:0002973 | |
| HumanPheno | Abnormal knee morphology | 1.13e-03 | 364 | 18 | 6 | HP:0034669 | |
| HumanPheno | Pes planus | 1.15e-03 | 365 | 18 | 6 | HP:0001763 | |
| HumanPheno | Genu varum | 1.17e-03 | 61 | 18 | 3 | HP:0002970 | |
| HumanPheno | Abnormal limb epiphysis morphology | 1.17e-03 | 138 | 18 | 4 | HP:0006505 | |
| HumanPheno | Myelopathy | 1.21e-03 | 15 | 18 | 2 | HP:0002196 | |
| HumanPheno | Abnormal upper limb epiphysis morphology | 1.35e-03 | 64 | 18 | 3 | HP:0003839 | |
| HumanPheno | Bowing of the legs | 1.49e-03 | 254 | 18 | 5 | HP:0002979 | |
| HumanPheno | Abnormality of upper limb joint | 1.57e-03 | 705 | 18 | 8 | HP:0009810 | |
| HumanPheno | Abnormal iliac wing morphology | 1.61e-03 | 68 | 18 | 3 | HP:0011867 | |
| HumanPheno | Abnormality of refraction | 1.63e-03 | 709 | 18 | 8 | HP:0000539 | |
| HumanPheno | Small joint hypermobilty | 1.68e-03 | 69 | 18 | 3 | HP:0430046 | |
| HumanPheno | Abnormality of the joints of the lower limbs | 1.75e-03 | 547 | 18 | 7 | HP:0100239 | |
| HumanPheno | Short limb dwarfism | 1.95e-03 | 19 | 18 | 2 | HP:0003505 | |
| HumanPheno | Abnormal pelvic girdle bone morphology | 1.98e-03 | 730 | 18 | 8 | HP:0002644 | |
| HumanPheno | Glomerular deposits | 2.16e-03 | 20 | 18 | 2 | HP:0030949 | |
| HumanPheno | Generalized osteoporosis | 2.16e-03 | 20 | 18 | 2 | HP:0040160 | |
| HumanPheno | Abnormal joint physiology | COL2A1 AP4E1 COL6A3 COL9A1 COL9A3 GLDN GALNS COL27A1 CAMTA1 ARID1A COL1A1 | 2.16e-03 | 1358 | 18 | 11 | HP:0034430 |
| HumanPheno | Abnormality of joint mobility | COL2A1 AP4E1 COL6A3 COL9A1 COL9A3 GLDN GALNS COL27A1 CAMTA1 ARID1A COL1A1 | 2.16e-03 | 1358 | 18 | 11 | HP:0011729 |
| HumanPheno | Abnormal epiphysis morphology | 2.26e-03 | 279 | 18 | 5 | HP:0005930 | |
| HumanPheno | Genu valgum | 2.28e-03 | 165 | 18 | 4 | HP:0002857 | |
| HumanPheno | Abnormal metacarpal epiphysis morphology | 2.38e-03 | 21 | 18 | 2 | HP:0005913 | |
| HumanPheno | Dwarfism | 2.38e-03 | 21 | 18 | 2 | HP:0001516 | |
| HumanPheno | Mild short stature | 2.38e-03 | 21 | 18 | 2 | HP:0003502 | |
| Domain | Collagen | COL2A1 COL4A3 COL4A4 COL4A6 COL6A3 COL9A1 COL9A3 GLDN COL16A1 COL21A1 COL28A1 COL27A1 COL5A3 COL6A5 COL22A1 MARCO COL1A1 | 2.46e-28 | 85 | 50 | 17 | PF01391 |
| Domain | Collagen | COL2A1 COL4A3 COL4A4 COL4A6 COL6A3 COL9A1 COL9A3 GLDN COL16A1 COL21A1 COL28A1 COL27A1 COL5A3 COL6A5 COL22A1 MARCO COL1A1 | 2.46e-28 | 85 | 50 | 17 | IPR008160 |
| Domain | TSPN | 2.63e-11 | 23 | 50 | 6 | SM00210 | |
| Domain | Laminin_G | 9.83e-09 | 58 | 50 | 6 | IPR001791 | |
| Domain | NC1_FIB | 1.48e-08 | 11 | 50 | 4 | PS51461 | |
| Domain | Fib_collagen_C | 1.48e-08 | 11 | 50 | 4 | IPR000885 | |
| Domain | Fib_collagen_C | 1.48e-08 | 11 | 50 | 4 | PD002078 | |
| Domain | COLFI | 1.48e-08 | 11 | 50 | 4 | SM00038 | |
| Domain | COLFI | 1.48e-08 | 11 | 50 | 4 | PF01410 | |
| Domain | C4 | 3.59e-07 | 6 | 50 | 3 | SM00111 | |
| Domain | - | 3.59e-07 | 6 | 50 | 3 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 3.59e-07 | 6 | 50 | 3 | IPR001442 | |
| Domain | NC1_IV | 3.59e-07 | 6 | 50 | 3 | PS51403 | |
| Domain | C4 | 3.59e-07 | 6 | 50 | 3 | PF01413 | |
| Domain | VWA | 3.86e-07 | 56 | 50 | 5 | PF00092 | |
| Domain | - | 1.57e-06 | 74 | 50 | 5 | 3.40.50.410 | |
| Domain | VWFA | 2.62e-06 | 82 | 50 | 5 | PS50234 | |
| Domain | VWA | 2.95e-06 | 84 | 50 | 5 | SM00327 | |
| Domain | VWF_A | 6.63e-06 | 99 | 50 | 5 | IPR002035 | |
| Domain | ConA-like_dom | 2.51e-05 | 219 | 50 | 6 | IPR013320 | |
| Domain | - | 1.21e-04 | 95 | 50 | 4 | 2.60.120.200 | |
| Domain | - | 1.05e-03 | 18 | 50 | 2 | 4.10.410.10 | |
| Domain | Prtase_inh_Kunz-CS | 1.05e-03 | 18 | 50 | 2 | IPR020901 | |
| Domain | KU | 1.05e-03 | 18 | 50 | 2 | SM00131 | |
| Domain | BPTI_KUNITZ_2 | 1.17e-03 | 19 | 50 | 2 | PS50279 | |
| Domain | Kunitz_BPTI | 1.17e-03 | 19 | 50 | 2 | PF00014 | |
| Domain | BPTI_KUNITZ_1 | 1.17e-03 | 19 | 50 | 2 | PS00280 | |
| Domain | Kunitz_BPTI | 1.71e-03 | 23 | 50 | 2 | IPR002223 | |
| Domain | VWC | 2.54e-03 | 28 | 50 | 2 | PF00093 | |
| Domain | CTDL_fold | 2.95e-03 | 107 | 50 | 3 | IPR016187 | |
| Domain | VWFC_1 | 4.18e-03 | 36 | 50 | 2 | PS01208 | |
| Domain | VWC | 4.64e-03 | 38 | 50 | 2 | SM00214 | |
| Domain | VWFC_2 | 4.64e-03 | 38 | 50 | 2 | PS50184 | |
| Domain | VWF_dom | 5.65e-03 | 42 | 50 | 2 | IPR001007 | |
| Domain | FN3 | 1.33e-02 | 185 | 50 | 3 | SM00060 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL2A1 COL4A3 COL4A4 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL28A1 COL27A1 COL5A3 COL6A5 COL22A1 COL1A1 | 4.21e-29 | 44 | 39 | 15 | M27812 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL2A1 COL4A3 COL4A4 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL28A1 COL27A1 COL5A3 COL6A5 COL22A1 COL1A1 | 6.11e-26 | 67 | 39 | 15 | M26999 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL2A1 COL4A3 COL4A4 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL28A1 COL5A3 COL6A5 COL22A1 COL1A1 | 9.84e-25 | 41 | 39 | 13 | MM15538 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL2A1 COL4A3 COL4A4 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL28A1 COL27A1 COL5A3 COL6A5 COL22A1 COL1A1 | 7.80e-24 | 90 | 39 | 15 | M631 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL2A1 COL4A3 COL4A4 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL28A1 COL5A3 COL6A5 COL22A1 COL1A1 | 3.54e-22 | 61 | 39 | 13 | MM14637 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL2A1 COL4A3 COL4A4 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL28A1 COL5A3 COL6A5 COL22A1 COL1A1 | 8.03e-21 | 76 | 39 | 13 | MM14573 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL2A1 COL4A3 COL4A4 COL4A6 COL6A3 COL9A1 COL9A3 COL27A1 COL5A3 COL6A5 COL1A1 | 5.87e-18 | 61 | 39 | 11 | M27103 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL2A1 COL4A3 COL4A4 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL5A3 COL6A5 COL1A1 | 1.04e-17 | 64 | 39 | 11 | M26953 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL2A1 COL4A3 COL4A4 COL4A6 COL6A3 COL9A1 COL9A3 COL5A3 COL6A5 COL1A1 | 7.12e-17 | 50 | 39 | 10 | MM14796 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL2A1 COL4A3 COL4A4 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL5A3 COL6A5 COL1A1 | 7.82e-17 | 76 | 39 | 11 | MM14867 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.96e-16 | 20 | 39 | 8 | MM15061 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL2A1 COL4A3 COL4A4 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL5A3 COL6A5 COL1A1 | 2.86e-16 | 85 | 39 | 11 | M16441 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL2A1 COL4A3 COL4A4 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL28A1 COL27A1 COL5A3 COL6A5 COL22A1 COL1A1 | 9.32e-16 | 300 | 39 | 15 | M610 |
| Pathway | PID_SYNDECAN_1_PATHWAY | COL2A1 COL4A3 COL4A4 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL1A1 | 3.60e-15 | 46 | 39 | 9 | M198 |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | COL2A1 COL4A3 COL4A4 COL4A6 COL6A3 COL9A1 COL9A3 COL5A3 COL6A5 COL1A1 | 6.30e-15 | 76 | 39 | 10 | M27219 |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 7.35e-14 | 38 | 39 | 8 | MM14969 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL2A1 COL4A3 COL4A4 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL5A3 COL6A5 COL1A1 | 8.23e-14 | 140 | 39 | 11 | M587 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL2A1 COL4A3 COL4A4 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL28A1 COL5A3 COL6A5 COL22A1 COL1A1 | 1.02e-13 | 258 | 39 | 13 | MM14572 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.76e-13 | 42 | 39 | 8 | M7169 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | COL2A1 COL4A3 COL4A4 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL1A1 | 3.42e-13 | 74 | 39 | 9 | M160 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.29e-12 | 53 | 39 | 8 | MM14566 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.39e-12 | 57 | 39 | 8 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.77e-12 | 58 | 39 | 8 | M2049 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 5.54e-12 | 63 | 39 | 8 | M11187 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 4.08e-11 | 47 | 39 | 7 | MM14925 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 2.58e-10 | 32 | 39 | 6 | MM14924 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 7.12e-10 | 114 | 39 | 8 | MM14571 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.21e-08 | 59 | 39 | 6 | M27218 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 2.41e-08 | 66 | 39 | 6 | M18 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 6.68e-08 | 15 | 39 | 4 | M27161 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.04e-07 | 84 | 39 | 6 | M7098 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.49e-07 | 18 | 39 | 4 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.49e-07 | 18 | 39 | 4 | MM14882 | |
| Pathway | WP_PI3KAKT_SIGNALING | COL2A1 COL4A3 COL4A4 COL4A6 COL6A3 COL9A1 COL9A3 COL6A5 COL1A1 | 2.71e-07 | 339 | 39 | 9 | M39736 |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 4.64e-07 | 261 | 39 | 8 | MM15676 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.05e-06 | 199 | 39 | 7 | M7253 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL2A1 COL4A3 COL4A4 COL6A3 COL9A1 COL9A3 COL27A1 COL5A3 COL6A5 COL1A1 | 1.27e-06 | 532 | 39 | 10 | M27870 |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.30e-06 | 30 | 39 | 4 | M27772 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL2A1 COL4A3 COL4A4 COL6A3 COL9A1 COL9A3 COL5A3 COL6A5 COL1A1 | 1.56e-06 | 418 | 39 | 9 | MM15587 |
| Pathway | BIOCARTA_NPP1_PATHWAY | 2.32e-06 | 10 | 39 | 3 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 2.32e-06 | 10 | 39 | 3 | MM1560 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | COL2A1 COL4A3 COL4A4 COL6A3 COL9A1 COL9A3 PSMF1 ROBO2 COL5A3 COL6A5 | 2.57e-06 | 575 | 39 | 10 | M29853 |
| Pathway | BIOCARTA_VITCB_PATHWAY | 3.18e-06 | 11 | 39 | 3 | M15422 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 4.23e-06 | 12 | 39 | 3 | MM1526 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 4.71e-06 | 41 | 39 | 4 | M27778 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 5.49e-06 | 13 | 39 | 3 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 5.49e-06 | 13 | 39 | 3 | M12950 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 5.71e-06 | 43 | 39 | 4 | M53 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 6.98e-06 | 14 | 39 | 3 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 6.98e-06 | 14 | 39 | 3 | M6487 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 8.71e-06 | 15 | 39 | 3 | MM14922 | |
| Pathway | WP_FOCAL_ADHESION | 1.62e-05 | 199 | 39 | 6 | M39402 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.84e-05 | 19 | 39 | 3 | MM15512 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 2.16e-05 | 20 | 39 | 3 | M15394 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 3.34e-05 | 23 | 39 | 3 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 3.34e-05 | 23 | 39 | 3 | MM1427 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 5.68e-05 | 502 | 39 | 8 | MM14537 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 6.47e-05 | 79 | 39 | 4 | M27643 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 7.55e-05 | 30 | 39 | 3 | M27216 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 7.55e-05 | 30 | 39 | 3 | MM15517 | |
| Pathway | WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES | 1.11e-04 | 6 | 39 | 2 | M39872 | |
| Pathway | WP_FOCAL_ADHESION | 1.55e-04 | 187 | 39 | 5 | MM15913 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL2A1 COL4A3 COL4A4 COL6A3 H1-8 COL9A1 COL9A3 PSMF1 ROBO2 COL5A3 COL6A5 ARID1A | 3.31e-04 | 1432 | 39 | 12 | M509 |
| Pathway | REACTOME_SIGNALING_BY_MET | 8.30e-04 | 67 | 39 | 3 | MM15345 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 1.24e-03 | 19 | 39 | 2 | M27221 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 1.38e-03 | 302 | 39 | 5 | M39719 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 1.94e-03 | 326 | 39 | 5 | MM15917 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 2.34e-03 | 96 | 39 | 3 | M39834 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 2.51e-03 | 27 | 39 | 2 | M27217 | |
| Pathway | WP_DYSREGULATED_MIRNA_TARGETING_IN_INSULINPI3KAKT_SIGNALING | 2.69e-03 | 28 | 39 | 2 | MM15957 | |
| Pathway | WP_GASTRIC_CANCER_NETWORK_2 | 3.51e-03 | 32 | 39 | 2 | M39497 | |
| Pathway | REACTOME_RHOV_GTPASE_CYCLE | 4.67e-03 | 37 | 39 | 2 | M41819 | |
| Pathway | REACTOME_RHOV_GTPASE_CYCLE | 4.67e-03 | 37 | 39 | 2 | MM15610 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 6.27e-03 | 43 | 39 | 2 | M39565 | |
| Pubmed | COL2A1 COL4A3 COL4A4 COL4A6 COL6A3 COL16A1 COL28A1 COL27A1 COL5A3 COL6A5 COL22A1 COL1A1 | 1.85e-17 | 175 | 50 | 12 | 28071719 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | COL2A1 COL4A3 COL4A6 COL6A3 COL16A1 COL21A1 COL28A1 COL5A3 COL6A5 COL1A1 | 4.98e-15 | 135 | 50 | 10 | 28675934 |
| Pubmed | COL4A3 COL4A4 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL28A1 COL1A1 | 1.78e-14 | 153 | 50 | 10 | 25037231 | |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 3.23e-14 | 62 | 50 | 8 | 28344315 | |
| Pubmed | COL4A4 COL4A6 COL6A3 COL9A3 COL16A1 COL28A1 COL27A1 COL5A3 COL6A5 COL1A1 | 4.32e-14 | 167 | 50 | 10 | 22159717 | |
| Pubmed | 5.72e-11 | 19 | 50 | 5 | 15689378 | ||
| Pubmed | 1.32e-10 | 7 | 50 | 4 | 9426396 | ||
| Pubmed | 2.63e-10 | 8 | 50 | 4 | 3997552 | ||
| Pubmed | 2.63e-10 | 8 | 50 | 4 | 9164858 | ||
| Pubmed | 2.63e-10 | 8 | 50 | 4 | 10382266 | ||
| Pubmed | 4.74e-10 | 9 | 50 | 4 | 9878537 | ||
| Pubmed | 7.88e-10 | 10 | 50 | 4 | 2446864 | ||
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 1.85e-09 | 12 | 50 | 4 | 12180907 | |
| Pubmed | Collagen II is essential for the removal of the notochord and the formation of intervertebral discs. | 5.10e-09 | 15 | 50 | 4 | 9832566 | |
| Pubmed | 1.12e-08 | 4 | 50 | 3 | 11724554 | ||
| Pubmed | Collagen type IX from human cartilage: a structural profile of intermolecular cross-linking sites. | 1.12e-08 | 4 | 50 | 3 | 8660302 | |
| Pubmed | Specific hybridization probes for mouse type I, II, III and IX collagen mRNAs. | 1.12e-08 | 4 | 50 | 3 | 2054384 | |
| Pubmed | 2.79e-08 | 5 | 50 | 3 | 9409248 | ||
| Pubmed | 4.67e-08 | 25 | 50 | 4 | 19180518 | ||
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 5.57e-08 | 6 | 50 | 3 | 9506531 | |
| Pubmed | Expression patterns of cartilage collagens and Sox9 during mouse heart development. | 5.57e-08 | 6 | 50 | 3 | 12883905 | |
| Pubmed | 5.57e-08 | 6 | 50 | 3 | 2426947 | ||
| Pubmed | Retarded skeletal development in transgenic mice with a type II collagen mutation. | 5.57e-08 | 6 | 50 | 3 | 8952549 | |
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 5.57e-08 | 6 | 50 | 3 | 23551189 | |
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 5.57e-08 | 6 | 50 | 3 | 6811420 | |
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 5.57e-08 | 6 | 50 | 3 | 6389236 | |
| Pubmed | 5.57e-08 | 6 | 50 | 3 | 12225806 | ||
| Pubmed | 5.57e-08 | 6 | 50 | 3 | 20301479 | ||
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 5.57e-08 | 6 | 50 | 3 | 10534397 | |
| Pubmed | 5.57e-08 | 6 | 50 | 3 | 8305476 | ||
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 5.57e-08 | 6 | 50 | 3 | 9673377 | |
| Pubmed | 5.57e-08 | 6 | 50 | 3 | 15922184 | ||
| Pubmed | 5.57e-08 | 6 | 50 | 3 | 11732842 | ||
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 5.57e-08 | 6 | 50 | 3 | 19275937 | |
| Pubmed | 5.57e-08 | 6 | 50 | 3 | 6988303 | ||
| Pubmed | Chondromodulin I is dispensable during enchondral ossification and eye development. | 6.47e-08 | 27 | 50 | 4 | 12192060 | |
| Pubmed | 9.75e-08 | 7 | 50 | 3 | 11711546 | ||
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 9.75e-08 | 7 | 50 | 3 | 8006028 | |
| Pubmed | Structure, chromosomal location, and tissue-specific expression of the mouse opticin gene. | 9.75e-08 | 7 | 50 | 3 | 11527931 | |
| Pubmed | 9.75e-08 | 7 | 50 | 3 | 10416788 | ||
| Pubmed | 9.75e-08 | 7 | 50 | 3 | 1724753 | ||
| Pubmed | Type II and type IX collagen transcript isoforms are expressed during mouse testis development. | 9.75e-08 | 7 | 50 | 3 | 12606408 | |
| Pubmed | The pro-alpha2(XI) collagen gene is expressed in odontoblasts. | 1.56e-07 | 8 | 50 | 3 | 20059976 | |
| Pubmed | 1.56e-07 | 8 | 50 | 3 | 29422532 | ||
| Pubmed | 1.56e-07 | 8 | 50 | 3 | 1377218 | ||
| Pubmed | A mouse model for dominant collagen VI disorders: heterozygous deletion of Col6a3 Exon 16. | 1.56e-07 | 8 | 50 | 3 | 24563484 | |
| Pubmed | Molecular properties of wild-type and mutant betaIG-H3 proteins. | 1.56e-07 | 8 | 50 | 3 | 11867580 | |
| Pubmed | Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons. | 1.56e-07 | 8 | 50 | 3 | 10970885 | |
| Pubmed | 2.33e-07 | 9 | 50 | 3 | 12101409 | ||
| Pubmed | 2.69e-07 | 38 | 50 | 4 | 25572963 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 2.92e-07 | 97 | 50 | 5 | 27559042 | |
| Pubmed | 3.33e-07 | 10 | 50 | 3 | 9415455 | ||
| Pubmed | 3.33e-07 | 10 | 50 | 3 | 9136074 | ||
| Pubmed | 4.58e-07 | 11 | 50 | 3 | 14998921 | ||
| Pubmed | 4.58e-07 | 11 | 50 | 3 | 9664687 | ||
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 4.58e-07 | 11 | 50 | 3 | 7500359 | |
| Pubmed | The Type 3 Deiodinase Is a Critical Modulator of Thyroid Hormone Sensitivity in the Fetal Brain. | 5.39e-07 | 45 | 50 | 4 | 34248495 | |
| Pubmed | 5.74e-07 | 210 | 50 | 6 | 16537572 | ||
| Pubmed | Basement membrane fragility underlies embryonic lethality in fukutin-null mice. | 6.09e-07 | 12 | 50 | 3 | 15837576 | |
| Pubmed | 6.09e-07 | 12 | 50 | 3 | 16024816 | ||
| Pubmed | 1.01e-06 | 14 | 50 | 3 | 12878203 | ||
| Pubmed | Perlecan maintains the integrity of cartilage and some basement membranes. | 1.26e-06 | 15 | 50 | 3 | 10579729 | |
| Pubmed | 1.41e-06 | 57 | 50 | 4 | 34003106 | ||
| Pubmed | 1.55e-06 | 16 | 50 | 3 | 15878328 | ||
| Pubmed | 1.86e-06 | 61 | 50 | 4 | 11180952 | ||
| Pubmed | Maturational disturbance of chondrocytes in Cbfa1-deficient mice. | 1.87e-06 | 17 | 50 | 3 | 10213384 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 12096843 | ||
| Pubmed | Mutation analysis of COL4A3 and COL4A4 genes in a Chinese autosomal-dominant Alport syndrome family. | 2.03e-06 | 2 | 50 | 2 | 28674241 | |
| Pubmed | Polypeptide composition of the mammalian tectorial membrane. | 2.03e-06 | 2 | 50 | 2 | 3542919 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 9537506 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 7987396 | ||
| Pubmed | Heterozygous COL4A3/COL4A4 mutations: the hidden part of the iceberg? | 2.03e-06 | 2 | 50 | 2 | 35090027 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 29742505 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 38214412 | ||
| Pubmed | Nine novel COL4A3 and COL4A4 mutations and polymorphisms identified in inherited membrane diseases. | 2.03e-06 | 2 | 50 | 2 | 17216251 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 35369551 | ||
| Pubmed | Expression of the mouse alpha 1(II) collagen gene is not restricted to cartilage during development. | 2.03e-06 | 2 | 50 | 2 | 1879363 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 25307543 | ||
| Pubmed | Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome. | 2.03e-06 | 2 | 50 | 2 | 27281700 | |
| Pubmed | [From Alport syndrome to benign familial hematuria: clinical and genetic aspect]. | 2.03e-06 | 2 | 50 | 2 | 16895672 | |
| Pubmed | Mice lacking alpha 1 (IX) collagen develop noninflammatory degenerative joint disease. | 2.03e-06 | 2 | 50 | 2 | 8197187 | |
| Pubmed | COL4A3/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome. | 2.03e-06 | 2 | 50 | 2 | 24052634 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 19357112 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 12768082 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 19387081 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 6320112 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 25229338 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 17942953 | ||
| Pubmed | Polymorphisms in COL4A3 and COL4A4 genes associated with keratoconus. | 2.03e-06 | 2 | 50 | 2 | 20029656 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 8204907 | ||
| Pubmed | Persistent familial hematuria in children and the locus for thin basement membrane nephropathy. | 2.03e-06 | 2 | 50 | 2 | 16235097 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 25381091 | ||
| Pubmed | Collagen type IV (alpha3-alpha4) nephropathy: from isolated haematuria to renal failure. | 2.03e-06 | 2 | 50 | 2 | 15280517 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 15880327 | ||
| Pubmed | Presumed COL4A3/COL4A4 Missense/Synonymous Variants Induce Aberrant Splicing. | 2.03e-06 | 2 | 50 | 2 | 35386907 | |
| Pubmed | COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome. | 2.03e-06 | 2 | 50 | 2 | 12028435 | |
| Pubmed | Polymorphism analysis of COL4A3 and COL4A4 genes in Greek patients with keratoconus. | 2.03e-06 | 2 | 50 | 2 | 25083577 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 20847057 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 18661361 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 32232700 | ||
| Interaction | LAIR2 interactions | 9.79e-08 | 49 | 47 | 5 | int:LAIR2 | |
| Interaction | TGFBI interactions | 3.17e-07 | 25 | 47 | 4 | int:TGFBI | |
| Interaction | COLGALT2 interactions | 4.80e-07 | 67 | 47 | 5 | int:COLGALT2 | |
| Interaction | MMP9 interactions | 4.80e-07 | 67 | 47 | 5 | int:MMP9 | |
| Interaction | MAG interactions | 5.91e-07 | 29 | 47 | 4 | int:MAG | |
| Interaction | DCN interactions | 3.00e-06 | 43 | 47 | 4 | int:DCN | |
| Interaction | CD93 interactions | 3.61e-06 | 45 | 47 | 4 | int:CD93 | |
| Interaction | PLOD1 interactions | 4.78e-06 | 292 | 47 | 7 | int:PLOD1 | |
| Interaction | HABP2 interactions | 9.47e-06 | 18 | 47 | 3 | int:HABP2 | |
| Interaction | COMP interactions | 1.32e-05 | 20 | 47 | 3 | int:COMP | |
| Interaction | OSM interactions | 1.32e-05 | 20 | 47 | 3 | int:OSM | |
| Interaction | COL2A1 interactions | 1.49e-05 | 64 | 47 | 4 | int:COL2A1 | |
| Interaction | MMP2 interactions | 5.02e-05 | 87 | 47 | 4 | int:MMP2 | |
| Interaction | PLOD3 interactions | 6.58e-05 | 183 | 47 | 5 | int:PLOD3 | |
| Interaction | MATN2 interactions | 1.39e-04 | 113 | 47 | 4 | int:MATN2 | |
| Interaction | C1QTNF1 interactions | 1.79e-04 | 47 | 47 | 3 | int:C1QTNF1 | |
| Interaction | COL9A3 interactions | 2.37e-04 | 10 | 47 | 2 | int:COL9A3 | |
| Interaction | MFSD13A interactions | 2.89e-04 | 11 | 47 | 2 | int:MFSD13A | |
| Interaction | SERPINE2 interactions | 3.02e-04 | 56 | 47 | 3 | int:SERPINE2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q36 | 1.13e-04 | 85 | 50 | 3 | chr2q36 | |
| Cytoband | 15q21.2 | 4.63e-04 | 29 | 50 | 2 | 15q21.2 | |
| Cytoband | 3q22.1 | 9.73e-04 | 42 | 50 | 2 | 3q22.1 | |
| GeneFamily | Collagens | COL2A1 COL4A3 COL4A4 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL28A1 COL27A1 COL5A3 COL6A5 COL22A1 COL1A1 | 2.94e-31 | 46 | 35 | 15 | 490 |
| GeneFamily | Collagens|Collagen proteoglycans | 3.63e-05 | 5 | 35 | 2 | 575 | |
| Coexpression | NABA_COLLAGENS | COL2A1 COL4A3 COL4A4 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL28A1 COL27A1 COL5A3 COL6A5 COL22A1 COL1A1 | 2.42e-31 | 44 | 49 | 15 | M3005 |
| Coexpression | NABA_COLLAGENS | COL2A1 COL4A3 COL4A4 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL28A1 COL27A1 COL5A3 COL6A5 COL22A1 COL1A1 | 6.18e-29 | 43 | 49 | 14 | MM17060 |
| Coexpression | NABA_CORE_MATRISOME | COL2A1 COL4A3 COL4A4 COL4A6 COL6A3 FNDC1 COL9A1 COL9A3 GLDN COL16A1 COL21A1 COL28A1 COL27A1 COL5A3 COL6A5 COL22A1 COL1A1 | 6.61e-22 | 275 | 49 | 17 | M5884 |
| Coexpression | NABA_CORE_MATRISOME | COL2A1 COL4A3 COL4A4 COL4A6 COL6A3 FNDC1 COL9A1 COL9A3 GLDN COL16A1 COL28A1 COL27A1 COL5A3 COL6A5 COL22A1 COL1A1 | 2.54e-20 | 270 | 49 | 16 | MM17057 |
| Coexpression | NABA_MATRISOME | COL2A1 COL4A3 COL4A4 COL4A6 COL6A3 FNDC1 COL9A1 COL9A3 GLDN COL16A1 COL21A1 TCHHL1 COL28A1 COL27A1 COL5A3 COL6A5 COL22A1 COL1A1 | 1.47e-13 | 1026 | 49 | 18 | M5889 |
| Coexpression | NABA_MATRISOME | COL2A1 COL4A3 COL4A4 COL4A6 COL6A3 FNDC1 COL9A1 COL9A3 GLDN COL16A1 TCHHL1 COL28A1 COL27A1 COL5A3 COL6A5 COL22A1 COL1A1 | 1.57e-12 | 1008 | 49 | 17 | MM17056 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.16e-08 | 40 | 49 | 5 | M5887 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_METASTASIS | 1.00e-06 | 11 | 49 | 3 | M47997 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | DENND2A COL6A3 FNDC1 GLDN COL16A1 COL21A1 COL28A1 COL5A3 DZIP1 COL1A1 | 1.27e-06 | 767 | 49 | 10 | M39209 |
| Coexpression | DESCARTES_ORGANOGENESIS_JAW_AND_TOOTH_PROGENITORS | 1.33e-06 | 12 | 49 | 3 | MM3646 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 2.65e-06 | 117 | 49 | 5 | M39300 | |
| Coexpression | GU_PDEF_TARGETS_UP | 9.55e-06 | 71 | 49 | 4 | M3955 | |
| Coexpression | PEREZ_TP53_TARGETS | COL2A1 ZFYVE28 COL4A4 COL9A3 GLDN COL21A1 COL27A1 COL22A1 DZIP1 CAMTA1 CYSRT1 | 1.04e-05 | 1201 | 49 | 11 | M4391 |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 2.17e-05 | 29 | 49 | 3 | MM17055 | |
| Coexpression | DESCARTES_FETAL_LIVER_MESOTHELIAL_CELLS | 2.51e-05 | 313 | 49 | 6 | M40228 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_METASTASIS_TUMOR_CELL_DERIVED | 3.41e-05 | 5 | 49 | 2 | M47996 | |
| Coexpression | MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3 | 3.53e-05 | 34 | 49 | 3 | M1955 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 3.85e-05 | 35 | 49 | 3 | MM17054 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 4.03e-05 | 505 | 49 | 7 | M39167 | |
| Coexpression | MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3 | 4.20e-05 | 36 | 49 | 3 | MM833 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_RESTING_CHONDROCYTE | 5.57e-05 | 111 | 49 | 4 | M45685 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_ASPN_POS_CHONDROCYTE | 6.84e-05 | 117 | 49 | 4 | M45663 | |
| Coexpression | SEMBA_FHIT_TARGETS_UP | 1.86e-04 | 11 | 49 | 2 | M14812 | |
| Coexpression | TRAVAGLINI_LUNG_MYOFIBROBLAST_CELL | 2.47e-04 | 65 | 49 | 3 | M41673 | |
| Coexpression | DESCARTES_FETAL_HEART_SCHWANN_CELLS | 2.70e-04 | 67 | 49 | 3 | M40194 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_INTERM_CHONDROCYTE | 2.82e-04 | 68 | 49 | 3 | M45669 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 2.95e-04 | 69 | 49 | 3 | M10165 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 3.63e-04 | 74 | 49 | 3 | M13547 | |
| Coexpression | ROSS_AML_WITH_PML_RARA_FUSION | 4.56e-04 | 80 | 49 | 3 | M15368 | |
| Coexpression | GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_IFNAR_KO_DN | 4.57e-04 | 192 | 49 | 4 | M9983 | |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 4.73e-04 | 81 | 49 | 3 | M39253 | |
| Coexpression | GSE9006_1MONTH_VS_4MONTH_POST_TYPE_1_DIABETES_DX_PBMC_DN | 4.94e-04 | 196 | 49 | 4 | M5791 | |
| Coexpression | LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP | 5.08e-04 | 83 | 49 | 3 | M15975 | |
| Coexpression | GSE13493_DP_VS_CD8POS_THYMOCYTE_UP | 5.23e-04 | 199 | 49 | 4 | M3314 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 5.33e-04 | 200 | 49 | 4 | M5930 | |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 6.63e-04 | 212 | 49 | 4 | M39221 | |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 6.64e-04 | 91 | 49 | 3 | M40180 | |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | 3.70e-11 | 188 | 50 | 8 | 7b1e3f8a941eaa68e89c562129a92314642eec66 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.06e-11 | 200 | 50 | 8 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.85e-10 | 157 | 50 | 7 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 1.47e-09 | 184 | 50 | 7 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.77e-09 | 189 | 50 | 7 | eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 1.77e-09 | 189 | 50 | 7 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.77e-09 | 189 | 50 | 7 | 40764f461b8aa1d3a2c5a30590b7fb9307d47d09 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-09 | 189 | 50 | 7 | e059be2965cca70ff5576df055d0af1775b76e00 | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.77e-09 | 189 | 50 | 7 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-09 | 192 | 50 | 7 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-09 | 192 | 50 | 7 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.05e-09 | 193 | 50 | 7 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | PND10-Mesenchymal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.28e-09 | 196 | 50 | 7 | ace167a40adb7022b365be3c2b1cbd4ba963739a | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.28e-09 | 196 | 50 | 7 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.36e-09 | 197 | 50 | 7 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.36e-09 | 197 | 50 | 7 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-09 | 198 | 50 | 7 | d3a475be01657a03fcbb0ee0a246b1e90deacaa4 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.45e-09 | 198 | 50 | 7 | 1f956e369e00d37835095a001db4b62a79014532 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.45e-09 | 198 | 50 | 7 | dc6fbad0ecdd057189f71afcdb6aca25207314a3 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.45e-09 | 198 | 50 | 7 | 1beed34f469aad07e8f674f0b668d6e1e916403c | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.45e-09 | 198 | 50 | 7 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-09 | 198 | 50 | 7 | 985022c1722ab7b67675ebe814022a439e715b5e | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 2.45e-09 | 198 | 50 | 7 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.62e-09 | 200 | 50 | 7 | 3dacd0afe69bc16bb33336ea9ea99a9cd47731d9 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 2.62e-09 | 200 | 50 | 7 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.62e-09 | 200 | 50 | 7 | ac8a5d71acd4d401995babd233f0d3738e8ad2a5 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.38e-08 | 158 | 50 | 6 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 2.48e-08 | 159 | 50 | 6 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.77e-08 | 162 | 50 | 6 | 3f264263878af630921911c2b344ac56eb1e7099 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 2.98e-08 | 164 | 50 | 6 | 9b4a6007abae992db871d9f6f731d5af724de30d | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.20e-08 | 166 | 50 | 6 | 37794a84601a2a949d579663d4a4bb8bc8fb5923 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.20e-08 | 166 | 50 | 6 | 81c546c6d847e49e662b81e71992ca0f7a99e890 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.09e-08 | 173 | 50 | 6 | ab6d3507301038f944ad59ccd848b5e6eeb76d04 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.18e-08 | 180 | 50 | 6 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.35e-08 | 181 | 50 | 6 | 22363c5835dd6cef8f895ab9362e0837d92b15b1 | |
| ToppCell | Mesenchymal_cells-Chondrocytes|World / Lineage and Cell class | 5.90e-08 | 184 | 50 | 6 | 1e03f9f08de5ad4d45388a95afad9f23ff0d0e28 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.90e-08 | 184 | 50 | 6 | 8fd8bd3d28d0ee6f0ef1f14e354d8eaf63a8081b | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.09e-08 | 185 | 50 | 6 | ca69499ba8c39b7ed6717d05685d6f70066a77bd | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.09e-08 | 185 | 50 | 6 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.09e-08 | 185 | 50 | 6 | b8052cebb73f41abe6faf0aa847be7c8ef23ae94 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 6.49e-08 | 187 | 50 | 6 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | E15.5-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.49e-08 | 187 | 50 | 6 | 1288fcd0124c70711521f3ac83554e9acdd37cb2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.70e-08 | 188 | 50 | 6 | 3cee9916399e2e7580cecbcbb27424a71e7e7ac0 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.92e-08 | 189 | 50 | 6 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 7.14e-08 | 190 | 50 | 6 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 7.14e-08 | 190 | 50 | 6 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-erythroid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.14e-08 | 190 | 50 | 6 | cf463b2f227f3cc7d3fd296c810c0cbe51cbee72 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.14e-08 | 190 | 50 | 6 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.36e-08 | 191 | 50 | 6 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.36e-08 | 191 | 50 | 6 | 5271198116343c07202649889057e5774d7fdde3 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.36e-08 | 191 | 50 | 6 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.59e-08 | 192 | 50 | 6 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.59e-08 | 192 | 50 | 6 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.59e-08 | 192 | 50 | 6 | 4ed5040594ba2d0639f0990697504ecef872ca70 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.59e-08 | 192 | 50 | 6 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 7.59e-08 | 192 | 50 | 6 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.59e-08 | 192 | 50 | 6 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.59e-08 | 192 | 50 | 6 | d4f5d6653564c2c5d0f5f7c932d89cb1b1412844 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.59e-08 | 192 | 50 | 6 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 7.59e-08 | 192 | 50 | 6 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.59e-08 | 192 | 50 | 6 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.83e-08 | 193 | 50 | 6 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.07e-08 | 194 | 50 | 6 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 8.07e-08 | 194 | 50 | 6 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.07e-08 | 194 | 50 | 6 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 8.32e-08 | 195 | 50 | 6 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | Fibroblast-B_(Myofibroblast)|World / shred on cell class and cell subclass (v4) | 8.32e-08 | 195 | 50 | 6 | a8d6416518f226e1ec2d6bdc9d4b90cef5cb1365 | |
| ToppCell | COVID-19-kidney-TAL|kidney / Disease (COVID-19 only), tissue and cell type | 8.58e-08 | 196 | 50 | 6 | 04f5eb206ed3016a737609a3ebac0c1fcabb94ef | |
| ToppCell | PCW_07-8.5-Mesenchymal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.58e-08 | 196 | 50 | 6 | 8e10802f52e5e1853ea4ad34bf9a32a34e6112b5 | |
| ToppCell | Mesenchymal_cells-Fibro/Chondro_p.|World / Lineage and Cell class | 8.58e-08 | 196 | 50 | 6 | ddc168849e0e97005a111be004463bb72d433853 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.58e-08 | 196 | 50 | 6 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.84e-08 | 197 | 50 | 6 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.84e-08 | 197 | 50 | 6 | 9d7a1c7dc70ba5e35645f19f9e056e4fa2494aa0 | |
| ToppCell | PND03-Mesenchymal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.84e-08 | 197 | 50 | 6 | e3053ef8f604b6892c21c03e12612b49d3d30f23 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.84e-08 | 197 | 50 | 6 | 090a251194da3e2806989d9a522588f83f52da7f | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.84e-08 | 197 | 50 | 6 | 26475b9e4d6bfc0ae818dea13d139888ed7e92f1 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.84e-08 | 197 | 50 | 6 | 43b5f8e917506c1717f9311584901b506ffd2c79 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.84e-08 | 197 | 50 | 6 | 155e63b33302a87393ace699b2f6d73abe9c5763 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.11e-08 | 198 | 50 | 6 | c55608633f66e3d434c5d81324efb07c5120d2c2 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.11e-08 | 198 | 50 | 6 | 3e5459038fc6ed95f529eb4d1dc5113e16c19012 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.11e-08 | 198 | 50 | 6 | a699b365d3b6149f13f02b2e2ae9b6fdce761848 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 9.11e-08 | 198 | 50 | 6 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.11e-08 | 198 | 50 | 6 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.11e-08 | 198 | 50 | 6 | a4005a49cf6709b543994ceb51ecd5dc46197fa9 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.11e-08 | 198 | 50 | 6 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.11e-08 | 198 | 50 | 6 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 9.11e-08 | 198 | 50 | 6 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.11e-08 | 198 | 50 | 6 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | droplet-Trachea|droplet / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.38e-08 | 199 | 50 | 6 | 1c7d30765ddb2291967da5d15664c6238c680c1d | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.38e-08 | 199 | 50 | 6 | ba586690f88fd051f449753bfe7603a2cb431782 | |
| ToppCell | 18-Airway-Mesenchymal-Cartilage|Airway / Age, Tissue, Lineage and Cell class | 9.38e-08 | 199 | 50 | 6 | f5d0aa4170367c080d3c2f01d9af3529762917fa | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 9.38e-08 | 199 | 50 | 6 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.38e-08 | 199 | 50 | 6 | da016849b804fbf80edbfa8f8f56c9df8bbf2d51 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.38e-08 | 199 | 50 | 6 | 84545ced0c792bc77980a50d65e484eab648d47e | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.38e-08 | 199 | 50 | 6 | 95d95e9b7bd3933188998ae94986213eb0f1e5ea | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.38e-08 | 199 | 50 | 6 | 36c1deac7ef0f9ebde6b2f7a63f7daa03d8c139a | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.38e-08 | 199 | 50 | 6 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 9.38e-08 | 199 | 50 | 6 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 9.38e-08 | 199 | 50 | 6 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.38e-08 | 199 | 50 | 6 | 38ed3bc7daa993d9edcf3e7834597ebb06dd24f8 | |
| Computational | Adhesion molecules. | 2.31e-05 | 141 | 27 | 5 | MODULE_122 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.56e-04 | 50 | 27 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Computational | Neighborhood of ZNF10 | 3.05e-04 | 53 | 27 | 3 | MORF_ZNF10 | |
| Computational | Neighborhood of DNM1 | 8.14e-04 | 74 | 27 | 3 | GNF2_DNM1 | |
| Drug | GK-101 | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL27A1 COL22A1 COL1A1 | 1.01e-21 | 36 | 50 | 11 | CID000161853 |
| Drug | Madecassol | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL27A1 COL22A1 COL1A1 | 2.21e-20 | 46 | 50 | 11 | CID000108062 |
| Drug | malotilate | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 GALNS COL21A1 COL27A1 COL22A1 COL1A1 | 3.51e-20 | 71 | 50 | 12 | CID000004006 |
| Drug | d-indobufen | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL27A1 COL22A1 COL1A1 | 6.16e-20 | 50 | 50 | 11 | CID000044562 |
| Drug | ridogrel | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL27A1 COL22A1 COL1A1 | 9.93e-20 | 52 | 50 | 11 | CID005362391 |
| Drug | NSC49633 | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL27A1 COL22A1 COL1A1 | 1.25e-19 | 53 | 50 | 11 | CID000023340 |
| Drug | AC1LAKND | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL27A1 COL22A1 COL1A1 | 8.23e-19 | 62 | 50 | 11 | CID000470146 |
| Drug | BAPN | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL27A1 COL22A1 COL1A1 | 4.09e-18 | 71 | 50 | 11 | CID000001647 |
| Drug | AC1NMZ1B | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL27A1 COL22A1 COL1A1 | 7.77e-18 | 75 | 50 | 11 | CID005034185 |
| Drug | hydroxylysine | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 GALNS COL21A1 COL27A1 COL22A1 COL1A1 | 8.11e-18 | 109 | 50 | 12 | CID000001029 |
| Drug | strontium ranelate | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL27A1 COL22A1 COL1A1 | 1.06e-17 | 77 | 50 | 11 | CID006918182 |
| Drug | halofuginone lactate | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL27A1 COL22A1 COL1A1 | 3.33e-17 | 85 | 50 | 11 | CID000062891 |
| Drug | 4-hydroxyproline | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL27A1 COL22A1 COL1A1 | 7.32e-17 | 91 | 50 | 11 | CID000000825 |
| Drug | DMSe | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL27A1 COL5A3 COL22A1 COL1A1 | 8.71e-17 | 132 | 50 | 12 | CID000020796 |
| Drug | ticlopidine | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL27A1 COL22A1 COL1A1 | 3.03e-16 | 103 | 50 | 11 | CID000005472 |
| Drug | AC1L1C2F | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL27A1 COL22A1 COL1A1 | 6.40e-16 | 110 | 50 | 11 | CID000001711 |
| Drug | PPACK | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL27A1 COL22A1 COL1A1 | 8.68e-16 | 113 | 50 | 11 | CID003036757 |
| Drug | AC1L9732 | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL27A1 COL22A1 COL1A1 | 9.60e-16 | 114 | 50 | 11 | CID000439300 |
| Drug | Tranilast sodium | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL27A1 COL22A1 COL1A1 | 1.06e-15 | 115 | 50 | 11 | CID000005527 |
| Drug | L-lysyl-L-lysyl-L-lysine | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 GALNS COL21A1 COL27A1 COL22A1 COL1A1 | 1.07e-15 | 162 | 50 | 12 | CID000072363 |
| Drug | Selara | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL27A1 COL22A1 COL1A1 | 2.72e-15 | 125 | 50 | 11 | CID000150310 |
| Drug | pirfenidone | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL27A1 COL22A1 COL1A1 | 8.26e-15 | 138 | 50 | 11 | CID000040632 |
| Drug | DL-penicillamine | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL27A1 COL22A1 COL1A1 | 8.96e-15 | 139 | 50 | 11 | CID000004727 |
| Drug | PCR 4099 | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL27A1 COL22A1 COL1A1 | 8.96e-15 | 139 | 50 | 11 | CID000002806 |
| Drug | candesartan cilexetil | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL27A1 COL22A1 COL1A1 | 1.44e-14 | 145 | 50 | 11 | CID000002540 |
| Drug | khellin | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL27A1 COL22A1 COL1A1 | 8.99e-14 | 171 | 50 | 11 | CID000003828 |
| Drug | AC1L1DD6 | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL27A1 COL22A1 COL1A1 | 1.49e-13 | 179 | 50 | 11 | CID000002299 |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL27A1 COL22A1 COL1A1 | 2.71e-13 | 189 | 50 | 11 | CID000001413 |
| Drug | foscarnet | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL27A1 COL22A1 COL1A1 | 2.87e-13 | 190 | 50 | 11 | CID000003414 |
| Drug | hyaluronan | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 GALNS COL21A1 COL27A1 COL22A1 COL1A1 | 3.61e-13 | 263 | 50 | 12 | CID000024759 |
| Drug | silibinin | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 GALNS COL21A1 COL27A1 COL22A1 COL1A1 | 9.33e-13 | 285 | 50 | 12 | CID000005213 |
| Drug | AC1Q6PCP | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL27A1 COL22A1 COL1A1 | 2.32e-12 | 230 | 50 | 11 | CID000005267 |
| Drug | prostacyclin sodium salt | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL27A1 COL22A1 COL1A1 | 5.75e-12 | 250 | 50 | 11 | CID000000159 |
| Drug | (2s,5s)-5-Carboxymethylproline | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL27A1 COL22A1 COL1A1 | 6.67e-11 | 314 | 50 | 11 | CID000447989 |
| Drug | chondroitin sulfate | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 GALNS COL21A1 COL27A1 COL22A1 COL1A1 | 7.06e-11 | 413 | 50 | 12 | CID000024766 |
| Drug | isodesmosine | 8.70e-11 | 33 | 50 | 6 | CID000013811 | |
| Drug | AC1L18QD | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL27A1 COL22A1 COL1A1 | 9.63e-11 | 325 | 50 | 11 | CID000000213 |
| Drug | L-3,4-dehydroproline | 2.32e-10 | 73 | 50 | 7 | CID000094284 | |
| Drug | AC1L1KMJ | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL27A1 COL22A1 MARCO COL1A1 | 3.59e-10 | 476 | 50 | 12 | CID000030956 |
| Drug | losartan | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL27A1 COL22A1 COL1A1 | 4.78e-10 | 378 | 50 | 11 | CID000003961 |
| Drug | NC-4 | 5.45e-10 | 44 | 50 | 6 | CID006420119 | |
| Drug | colchine | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL27A1 COL22A1 COL1A1 | 5.49e-10 | 383 | 50 | 11 | CID000002833 |
| Drug | dermatan sulfate | COL2A1 COL4A3 COL6A3 COL9A1 COL9A3 GALNS COL21A1 COL27A1 COL1A1 | 1.11e-09 | 220 | 50 | 9 | CID000032756 |
| Drug | desmosine | 1.75e-09 | 53 | 50 | 6 | CID000025435 | |
| Drug | Y-27632 | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL27A1 COL22A1 COL1A1 | 2.58e-09 | 444 | 50 | 11 | CID000005711 |
| Drug | LMWH | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 GALNS COL21A1 COL27A1 COL22A1 COL1A1 | 1.48e-08 | 663 | 50 | 12 | CID000000772 |
| Drug | aspirin | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL27A1 COL22A1 COL1A1 | 2.99e-08 | 563 | 50 | 11 | CID000002244 |
| Drug | NSC-333492 | 3.98e-08 | 4 | 50 | 3 | CID000333256 | |
| Drug | pyridinoline | 7.89e-08 | 99 | 50 | 6 | CID000105068 | |
| Drug | 351A | 9.71e-08 | 20 | 50 | 4 | CID000122144 | |
| Drug | BPAT-143 | 1.98e-07 | 6 | 50 | 3 | CID000146249 | |
| Drug | Sirius red | 1.02e-06 | 35 | 50 | 4 | CID005486818 | |
| Drug | LS-63783 | COL2A1 COL4A3 COL4A6 COL6A3 COL9A1 COL9A3 COL16A1 COL21A1 COL27A1 COL22A1 COL1A1 | 1.05e-06 | 804 | 50 | 11 | CID000000231 |
| Drug | AC1MRIIV | 1.60e-06 | 39 | 50 | 4 | CID003518584 | |
| Drug | AC1L9HPX | 1.77e-06 | 92 | 50 | 5 | CID000445279 | |
| Drug | PD123177 | 2.38e-06 | 43 | 50 | 4 | CID000114899 | |
| Drug | 1zd2 | 2.87e-06 | 45 | 50 | 4 | CID004149241 | |
| Drug | SC 19220; Down 200; 10uM; PC3; HT_HG-U133A | 3.88e-06 | 192 | 50 | 6 | 7065_DN | |
| Drug | 1h00 | 6.95e-06 | 56 | 50 | 4 | CID000445950 | |
| Drug | trapidil | 7.46e-06 | 57 | 50 | 4 | CID000005531 | |
| Drug | AC1Q641C | 1.05e-05 | 62 | 50 | 4 | CID000005005 | |
| Drug | calcium phosphate | 1.88e-05 | 149 | 50 | 5 | CID000024441 | |
| Drug | 8-azaguanine | 2.60e-05 | 78 | 50 | 4 | CID000008646 | |
| Drug | Collagenase | 2.83e-05 | 4 | 50 | 2 | DB00048 | |
| Drug | diacetylrhein | 2.83e-05 | 4 | 50 | 2 | ctd:C025292 | |
| Drug | toluidine blue | 3.17e-05 | 82 | 50 | 4 | CID000007083 | |
| Drug | homocystine | 3.17e-05 | 82 | 50 | 4 | CID000010010 | |
| Drug | etodolac | 4.73e-05 | 32 | 50 | 3 | CID000003308 | |
| Drug | sodium dodecyl sulfate | 4.78e-05 | 91 | 50 | 4 | CID000008778 | |
| Drug | dimethylnitrosamine | 6.95e-05 | 196 | 50 | 5 | CID000006124 | |
| Drug | Diphosphonates | 7.05e-05 | 6 | 50 | 2 | ctd:D004164 | |
| Drug | AG-H-50319 | 7.05e-05 | 6 | 50 | 2 | CID011819195 | |
| Drug | In2-7 | 7.05e-05 | 6 | 50 | 2 | CID002816385 | |
| Drug | 0225151-0000 [351320-15-5]; Up 200; 10uM; PC3; HT_HG-U133A | 7.12e-05 | 197 | 50 | 5 | 6389_UP | |
| Drug | Gabazine [105538-73-6]; Up 200; 10.8uM; PC3; HT_HG-U133A | 7.29e-05 | 198 | 50 | 5 | 4236_UP | |
| Drug | Etanidazole [22668-01-5]; Up 200; 18.6uM; PC3; HT_HG-U133A | 7.65e-05 | 200 | 50 | 5 | 5730_UP | |
| Drug | NSC636590 | 1.31e-04 | 8 | 50 | 2 | CID000072285 | |
| Drug | 3,4,5-trihydroxy-N-(4-(thiazol-2-ylsulfamoyl)-phenyl)-benzamide | 1.31e-04 | 8 | 50 | 2 | ctd:C000594958 | |
| Drug | safranin | 1.82e-04 | 50 | 50 | 3 | CID002723800 | |
| Drug | diacerein | 3.61e-04 | 63 | 50 | 3 | CID000026248 | |
| Drug | gluconate | 4.09e-04 | 287 | 50 | 5 | CID000000604 | |
| Drug | 4-aminoazobenzene | 4.14e-04 | 66 | 50 | 3 | CID000006051 | |
| Drug | glycolic acid | 4.14e-04 | 66 | 50 | 3 | CID000000757 | |
| Drug | Span 40 | 4.23e-04 | 14 | 50 | 2 | CID000014927 | |
| Drug | diphenylamine-2-carboxylate | 4.62e-04 | 164 | 50 | 4 | CID000004386 | |
| Drug | ascorbate-2-phosphate | 4.87e-04 | 15 | 50 | 2 | ctd:C011669 | |
| Drug | panobinostat | DENND2A COL6A3 SPAG1 COL9A3 COL21A1 SGPP2 USP43 ROBO2 COL5A3 COL1A1 | 5.48e-04 | 1333 | 50 | 10 | ctd:C496932 |
| Drug | chrysene | 5.73e-04 | 871 | 50 | 8 | ctd:C031180 | |
| Drug | calcium pyrophosphate | 5.79e-04 | 74 | 50 | 3 | CID000024632 | |
| Drug | AC1L8TZY | 6.26e-04 | 76 | 50 | 3 | CID000408095 | |
| Drug | crj | 6.29e-04 | 17 | 50 | 2 | CID011840933 | |
| Disease | Stickler syndrome (is_implicated_in) | 1.61e-08 | 4 | 48 | 3 | DOID:0080046 (is_implicated_in) | |
| Disease | collagen disease (implicated_via_orthology) | 8.80e-07 | 12 | 48 | 3 | DOID:854 (implicated_via_orthology) | |
| Disease | benign familial hematuria (is_implicated_in) | 2.59e-06 | 2 | 48 | 2 | DOID:0111365 (is_implicated_in) | |
| Disease | Alport syndrome, recessive type | 2.59e-06 | 2 | 48 | 2 | C2931254 | |
| Disease | Alport syndrome, dominant type | 2.59e-06 | 2 | 48 | 2 | C2931253 | |
| Disease | ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE | 2.59e-06 | 2 | 48 | 2 | C4746745 | |
| Disease | autosomal recessive Alport syndrome (is_implicated_in) | 2.59e-06 | 2 | 48 | 2 | DOID:0110033 (is_implicated_in) | |
| Disease | Thin basement membrane disease | 2.59e-06 | 2 | 48 | 2 | C0403440 | |
| Disease | Benign familial hematuria | 2.59e-06 | 2 | 48 | 2 | cv:C0241908 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 3.84e-06 | 19 | 48 | 3 | DOID:2256 (is_implicated_in) | |
| Disease | Multiple Epiphyseal Dysplasia | 4.52e-06 | 20 | 48 | 3 | C0026760 | |
| Disease | Disproportionate short stature | 7.64e-06 | 77 | 48 | 4 | C0878659 | |
| Disease | Stickler syndrome (disorder) | 7.77e-06 | 3 | 48 | 2 | C0265253 | |
| Disease | autosomal recessive Alport syndrome (implicated_via_orthology) | 7.77e-06 | 3 | 48 | 2 | DOID:0110033 (implicated_via_orthology) | |
| Disease | Alport syndrome | 7.77e-06 | 3 | 48 | 2 | cv:C1567741 | |
| Disease | Collagen IV-related nephropathies | 7.77e-06 | 3 | 48 | 2 | cv:CN076135 | |
| Disease | Hematuria, Benign Familial | 1.55e-05 | 4 | 48 | 2 | C0241908 | |
| Disease | Alport Syndrome | 1.55e-05 | 4 | 48 | 2 | C1567741 | |
| Disease | Stickler syndrome, type 1 | 2.58e-05 | 5 | 48 | 2 | C2020284 | |
| Disease | Stickler syndrome | 2.58e-05 | 5 | 48 | 2 | cv:C0265253 | |
| Disease | Multiple Epiphyseal Dysplasia, Dominant | 2.58e-05 | 5 | 48 | 2 | cv:CN043640 | |
| Disease | Alport Syndrome, X-Linked | 2.58e-05 | 5 | 48 | 2 | C1567742 | |
| Disease | Alport Syndrome, Autosomal Dominant | 2.58e-05 | 5 | 48 | 2 | C1567743 | |
| Disease | Alport Syndrome, Autosomal Recessive | 2.58e-05 | 5 | 48 | 2 | C1567744 | |
| Disease | hypertensive nephropathy | 3.87e-05 | 6 | 48 | 2 | C0848548 | |
| Disease | myopathy (implicated_via_orthology) | 6.64e-05 | 48 | 48 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | Hereditary hearing loss and deafness | 9.45e-05 | 146 | 48 | 4 | cv:C0236038 | |
| Disease | Sensory hearing loss | 1.41e-04 | 11 | 48 | 2 | C1691779 | |
| Disease | macula measurement | 2.55e-04 | 189 | 48 | 4 | EFO_0008375 | |
| Disease | osteoarthritis (implicated_via_orthology) | 2.68e-04 | 15 | 48 | 2 | DOID:8398 (implicated_via_orthology) | |
| Disease | Myopia | 2.68e-04 | 15 | 48 | 2 | C0027092 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 3.06e-04 | 16 | 48 | 2 | C4551479 | |
| Disease | Spondyloepiphyseal Dysplasia | 3.06e-04 | 16 | 48 | 2 | C0038015 | |
| Disease | Schwartz-Jampel Syndrome | 3.06e-04 | 16 | 48 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 3.06e-04 | 16 | 48 | 2 | C0025237 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 3.06e-04 | 16 | 48 | 2 | C3541456 | |
| Disease | Cleft Palate | 3.15e-04 | 81 | 48 | 3 | C0008925 | |
| Disease | response to radiation, Urinary retention | 3.47e-04 | 17 | 48 | 2 | GO_0009314, HP_0000016 | |
| Disease | Van Buchem disease | 3.47e-04 | 17 | 48 | 2 | C0432272 | |
| Disease | MHPG measurement, 5-HIAA measurement | 3.47e-04 | 17 | 48 | 2 | EFO_0005132, EFO_0005133 | |
| Disease | Dyschondroplasias | 4.35e-04 | 19 | 48 | 2 | C0013366 | |
| Disease | Osteochondrodysplasias | 4.35e-04 | 19 | 48 | 2 | C0029422 | |
| Disease | smoking behaviour measurement | 4.68e-04 | 222 | 48 | 4 | EFO_0005671 | |
| Disease | Renal glomerular disease | 6.41e-04 | 23 | 48 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 6.41e-04 | 23 | 48 | 2 | C4521256 | |
| Disease | Sensorineural Hearing Loss (disorder) | 6.41e-04 | 23 | 48 | 2 | C0018784 | |
| Disease | Intrahepatic Cholangiocarcinoma | 6.99e-04 | 24 | 48 | 2 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 6.99e-04 | 24 | 48 | 2 | C3805278 | |
| Disease | Early Pregnancy Loss | 7.51e-04 | 109 | 48 | 3 | C3830362 | |
| Disease | Miscarriage | 7.51e-04 | 109 | 48 | 3 | C4552766 | |
| Disease | Spontaneous abortion | 7.51e-04 | 109 | 48 | 3 | C0000786 | |
| Disease | Abortion, Tubal | 7.51e-04 | 109 | 48 | 3 | C0000822 | |
| Disease | Cholangiocarcinoma | 8.21e-04 | 26 | 48 | 2 | C0206698 | |
| Disease | Bilateral Wilms Tumor | 1.02e-03 | 29 | 48 | 2 | C2930471 | |
| Disease | obsolete aging | 1.10e-03 | 279 | 48 | 4 | GO_0007568 | |
| Disease | joint hypermobility measurement | 1.32e-03 | 33 | 48 | 2 | EFO_0007905 | |
| Disease | retinal detachment, retinal break | 1.49e-03 | 35 | 48 | 2 | EFO_0005773, EFO_0010698 | |
| Disease | Nephroblastoma | 1.58e-03 | 36 | 48 | 2 | C0027708 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NPKQGQTYGGGGLKA | 491 | Q9Y6Y1 | |
| DPGAQGPVGLQGSKG | 1396 | Q14031 | |
| AGRNGAPGEKGPNGL | 321 | Q14050 | |
| GAKGEQGDKGNPGPS | 931 | Q01955 | |
| PKGAKGNQGAAPIQN | 66 | A8MQ03 | |
| KGQKGDAGNPGDPGT | 681 | Q07092 | |
| PKGDPGAAGQKGQAG | 1366 | Q07092 | |
| GVNGQKGIPGDPAFG | 751 | P53420 | |
| LGLQGNEGPPGQKGE | 201 | Q6ZMI3 | |
| EGKKPGNNEGSGAPS | 286 | O60641 | |
| PQAGSRGGQGPKHGQ | 21 | Q9NQ90 | |
| FLQNQPGGGPAAAKA | 16 | Q9UPM8 | |
| QGEAGQKGDAGAPGP | 851 | P02458 | |
| NAPNPGGGDLQKAGK | 141 | P48200 | |
| DPGPQAGAGAGAKDK | 696 | Q17RG1 | |
| ADPQEKGQGGPGGAA | 431 | Q9HCC9 | |
| GGGPGAEPDLKNSNG | 91 | O14497 | |
| NNQPKIGGPLGTGAF | 451 | P52948 | |
| AGQGPNTKAAAPAKG | 291 | Q8IZA3 | |
| GKGPGNPANLSGTKG | 216 | Q8IWD5 | |
| GALGLQQGKSPGAGN | 441 | Q32MK0 | |
| SQKICNGGLSPGNPG | 361 | Q9H792 | |
| GGGPDGLDALKNKPQ | 306 | Q8N414 | |
| QANGPAAGRGTPKGK | 1011 | Q92900 | |
| APEQGGSNGPFLCGK | 296 | P34059 | |
| IKGERGPKGNPGNAQ | 261 | Q2UY09 | |
| GPKGNPGNAQKGEAG | 266 | Q2UY09 | |
| KGSKGNQGQRGLPGP | 556 | Q2UY09 | |
| NKGAVNVGGQDPEPG | 111 | Q9ULE3 | |
| EGKVLPGSNGKPNGQ | 1331 | Q4ZHG4 | |
| PGDPGNPGQNNNIKG | 1511 | A8TX70 | |
| PQGSQGNPGRKGEKG | 1586 | A8TX70 | |
| GFPGDAGQKGDIGNP | 1671 | A8TX70 | |
| NKGGPGQPGFEGEQG | 2211 | P12111 | |
| QPGQDGKPGYQGIAG | 471 | Q96P44 | |
| DPGFQGDKGSQGLPG | 866 | Q8IZC6 | |
| LDGFPGKPGDTGQQG | 606 | Q8NFW1 | |
| LQGPQGAPGKQGATG | 206 | Q9UEW3 | |
| AGFPGAKGDQGQPGL | 291 | Q9UEW3 | |
| AKGDQGQPGLQGVPG | 296 | Q9UEW3 | |
| PKGAPGQAGQKGDQG | 386 | Q9UEW3 | |
| QADLDGPPGAGKQGI | 146 | Q92837 | |
| KPGQMGNSGKPGQQG | 596 | P20849 | |
| KGQAGQAGEEGPPGS | 766 | P25940 | |
| ATGQPGPKGDVGQDG | 846 | P25940 | |
| FGLGVGDQPGPNDKK | 36 | Q92530 | |
| GAFNPKGPKGEGLQE | 831 | Q86YF9 | |
| LPAANGKGGEAPANG | 51 | Q8IWX5 | |
| AGGPAQKLQGNGVAG | 536 | Q7Z6J0 | |
| GNPGADGQPGAKGAN | 386 | P02452 | |
| DGQPGAKGANGAPGI | 391 | P02452 | |
| AKGANGAPGIAGAPG | 396 | P02452 | |
| PRGANGAPGNDGAKG | 696 | P02452 | |
| QKAGQGGLPKADAQG | 6 | Q96EG3 | |
| AGDGARPPGAQGLKN | 91 | Q70EL4 | |
| GPQNDGKQLAPGKAN | 131 | Q7RTT4 | |
| PGGGQGAENPAGLKS | 436 | Q07617 | |
| SLPDQNKGNNGGKGG | 1036 | Q9HCK4 | |
| NLQKRQAPGPGAAGG | 21 | Q8N9V7 | |
| GEHKNQGPGTKGPGA | 631 | Q5QJ38 | |
| RAQKGSPGVNGGPGD | 46 | O15016 | |
| GGVQPQAGDGAQTPK | 406 | Q9BRZ2 |